UPDATE 1-Moderna says US FDA refuses to review its influenza vaccine
Moderna +1.74%
Moderna MRNA | 53.76 | +1.74% |
Adds details in paragraph 2-3
Feb 10 (Reuters) - Moderna MRNA.O said on Tuesday the U.S. Food and Drug Administration will not review its approval application for its influenza vaccine.
The company said it had exercised a priority review voucher to fast track its application.
Moderna said it has requested a meeting with the regulator to understand the path forward.
